The Landscape of Cell and Gene Therapies for Solid Tumors

Shuhang Wang; Fa Sun; Huiyao Huang; Kun Chen; Qi Jing Li; Lu Zhang; Enxiu Wang; Chen Wang; Hai Zhang; Andy Qingan Yuan; Bin Chen; Tao Deng; Yarong Liu; Jingwei Sun; Dongfang Liu; Yue Yu; Yuan Fang; Ning Jiang; Dawei Wu; Hong Fang; Ying Bai; Shujun Xing; Yufen Ni; Qi Fan; Anqi Yu; Chao Sun; Yu Tang; Ning Li; Binghe Xu; Jie He

doi:10.1016/j.ccell.2020.12.005

The Landscape of Cell and Gene Therapies for Solid Tumors

Shuhang Wang, Fa Sun, Huiyao Huang, Kun Chen, Qi Jing Li, Lu Zhang, Enxiu Wang, Chen Wang, Hai Zhang, Andy Qingan Yuan, Bin Chen, Tao Deng, Yarong Liu, Jingwei Sun, Dongfang Liu, Yue Yu, Yuan Fang, Ning Jiang, Dawei Wu, Hong FangYing Bai, Shujun Xing, Yufen Ni, Qi Fan, Anqi Yu, Chao Sun, Yu Tang, Ning Li, Binghe Xu, Jie He

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	7-8
Number of pages	2
Journal	Cancer Cell
Volume	39
Issue number	1
DOIs	https://doi.org/10.1016/j.ccell.2020.12.005
State	Published - Jan 11 2021

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1016/j.ccell.2020.12.005

Cite this

@article{36c2a6f994ea4221a9f3d6c59e876678,

title = "The Landscape of Cell and Gene Therapies for Solid Tumors",

author = "Shuhang Wang and Fa Sun and Huiyao Huang and Kun Chen and Li, {Qi Jing} and Lu Zhang and Enxiu Wang and Chen Wang and Hai Zhang and Yuan, {Andy Qingan} and Bin Chen and Tao Deng and Yarong Liu and Jingwei Sun and Dongfang Liu and Yue Yu and Yuan Fang and Ning Jiang and Dawei Wu and Hong Fang and Ying Bai and Shujun Xing and Yufen Ni and Qi Fan and Anqi Yu and Chao Sun and Yu Tang and Ning Li and Binghe Xu and Jie He",

note = "Funding Information: This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (Platform Improvement of Clinical Trial Capability 2020-I2M-2-007), Chinese Academy of Medical Sciences (grant 2019XK320068), and Beijing Municipal Science and Technology Commission (International Pharmaceutical Clinical Research and Development Platform 2015). Q.-J.L. is a co-founder and stockholder for TCRCure Biopharma. T.D. is the founder of Chengdu MedGenCell Co Ltd. Chengdu, Sichuan, China. Funding Information: This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (Platform Improvement of Clinical Trial Capability 2020-I2M-2-007 ), Chinese Academy of Medical Sciences (grant 2019XK320068 ), and Beijing Municipal Science and Technology Commission ( International Pharmaceutical Clinical Research and Development Platform 2015 ). ",

year = "2021",

month = jan,

day = "11",

doi = "10.1016/j.ccell.2020.12.005",

language = "English (US)",

volume = "39",

pages = "7--8",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "1",

}

Wang, S, Sun, F, Huang, H, Chen, K, Li, QJ, Zhang, L, Wang, E, Wang, C, Zhang, H, Yuan, AQ, Chen, B, Deng, T, Liu, Y, Sun, J, Liu, D, Yu, Y, Fang, Y, Jiang, N, Wu, D, Fang, H, Bai, Y, Xing, S, Ni, Y, Fan, Q, Yu, A, Sun, C, Tang, Y, Li, N, Xu, B & He, J 2021, 'The Landscape of Cell and Gene Therapies for Solid Tumors', Cancer Cell, vol. 39, no. 1, pp. 7-8. https://doi.org/10.1016/j.ccell.2020.12.005

TY - JOUR

T1 - The Landscape of Cell and Gene Therapies for Solid Tumors

AU - Wang, Shuhang

AU - Sun, Fa

AU - Huang, Huiyao

AU - Chen, Kun

AU - Li, Qi Jing

AU - Zhang, Lu

AU - Wang, Enxiu

AU - Wang, Chen

AU - Zhang, Hai

AU - Yuan, Andy Qingan

AU - Chen, Bin

AU - Deng, Tao

AU - Liu, Yarong

AU - Sun, Jingwei

AU - Liu, Dongfang

AU - Yu, Yue

AU - Fang, Yuan

AU - Jiang, Ning

AU - Wu, Dawei

AU - Fang, Hong

AU - Bai, Ying

AU - Xing, Shujun

AU - Ni, Yufen

AU - Fan, Qi

AU - Yu, Anqi

AU - Sun, Chao

AU - Tang, Yu

AU - Li, Ning

AU - Xu, Binghe

AU - He, Jie

N1 - Funding Information: This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (Platform Improvement of Clinical Trial Capability 2020-I2M-2-007), Chinese Academy of Medical Sciences (grant 2019XK320068), and Beijing Municipal Science and Technology Commission (International Pharmaceutical Clinical Research and Development Platform 2015). Q.-J.L. is a co-founder and stockholder for TCRCure Biopharma. T.D. is the founder of Chengdu MedGenCell Co Ltd. Chengdu, Sichuan, China. Funding Information: This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (Platform Improvement of Clinical Trial Capability 2020-I2M-2-007 ), Chinese Academy of Medical Sciences (grant 2019XK320068 ), and Beijing Municipal Science and Technology Commission ( International Pharmaceutical Clinical Research and Development Platform 2015 ).

PY - 2021/1/11

Y1 - 2021/1/11

UR - http://www.scopus.com/inward/record.url?scp=85098953814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098953814&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2020.12.005

DO - 10.1016/j.ccell.2020.12.005

M3 - Letter

C2 - 33434513

AN - SCOPUS:85098953814

SN - 1535-6108

VL - 39

SP - 7

EP - 8

JO - Cancer Cell

JF - Cancer Cell

IS - 1

ER -

The Landscape of Cell and Gene Therapies for Solid Tumors

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this